183 related articles for article (PubMed ID: 6348785)
1. Rationale for the clinical studies of anemia treated with the perfluorochemical emulsion: Fluosol DA 20%.
Tremper KK
Prog Clin Biol Res; 1983; 122():307-13. PubMed ID: 6348785
[No Abstract] [Full Text] [Related]
2. Fluosol-DA as a red-cell substitute in acute anemia.
N Engl J Med; 1986 Dec; 315(26):1677-8. PubMed ID: 3785341
[No Abstract] [Full Text] [Related]
3. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
Tremper KK; Anderson ST
Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
[TBL] [Abstract][Full Text] [Related]
4. Initial results of a clinical trial of Fluosol-DA 20 percent in acute cerebral ischemia.
Swann KW; Ropper AH; Zervas NT
Prog Clin Biol Res; 1983; 122():399-404. PubMed ID: 6348787
[TBL] [Abstract][Full Text] [Related]
5. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
Suyama T; Yokoyama K; Naito R
Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
[TBL] [Abstract][Full Text] [Related]
6. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
Ishikawa R; Peerless SJ; Hunter IG
No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
[TBL] [Abstract][Full Text] [Related]
7. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA.
Tremper KK; Friedman AE; Levine EM; Lapin R; Camarillo D
N Engl J Med; 1982 Jul; 307(5):277-83. PubMed ID: 7045667
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with Fluosol-DA (20%) in the United States.
Tremper KK; Levine EM; Waxman K
Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514
[No Abstract] [Full Text] [Related]
9. Clinical experience with Fluosol-DA.
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
[TBL] [Abstract][Full Text] [Related]
10. [Clinical experience of hemodilution with fluosol-DA (author's transl)].
Fukushima K; Nakamura M; Takemura R
Masui; 1981 Jul; 30(7):741-5. PubMed ID: 7321165
[No Abstract] [Full Text] [Related]
11. Fluosol-DA as a red-cell substitute in acute anemia.
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
[TBL] [Abstract][Full Text] [Related]
12. Current perspectives on blood substitutes.
Gould SA; Moss G
Curr Surg; 1987; 44(4):279-81. PubMed ID: 3665573
[No Abstract] [Full Text] [Related]
13. New treatment of cerebral vasospasm with Fluosol-DA 20%: protective effect on cerebral ischemia and change of cerebral blood flow (CBF).
Handa H; Nagasawa S; Yonekawa Y; Naruo Y; Oda Y
Prog Clin Biol Res; 1983; 122():299-306. PubMed ID: 6878374
[TBL] [Abstract][Full Text] [Related]
14. Fluosol: therapeutic failure in severe anemia.
Kale PB; Sklar GE; Wesolowicz LA; DiLisio RE
Ann Pharmacother; 1993 Dec; 27(12):1452-4. PubMed ID: 8305774
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
Oda Y; Murata T; Uchida Y; Mori K; Nagasawa S; Naruo Y; Asato R; Handa H
No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
[TBL] [Abstract][Full Text] [Related]
16. Canadian Red Cross lecture. Current concepts of oxygen-transporting blood substitutes.
Bolin RB
Can J Surg; 1982 Jul; 25(4):422-4. PubMed ID: 7046893
[TBL] [Abstract][Full Text] [Related]
17. Use of Fluosol-DA during open-heart surgery.
Engelman RM; Dobbs WA; Rousou JH; Anisimowicz L
Prog Clin Biol Res; 1983; 122():273-82. PubMed ID: 6878370
[TBL] [Abstract][Full Text] [Related]
18. U.S. clinical studies of the treatment of anemia with fluosol-DA 20%.
Tremper KK; Cullen BF
Artif Organs; 1984 Feb; 8(1):19-24. PubMed ID: 6367719
[TBL] [Abstract][Full Text] [Related]
19. Use of a whole blood substitute, Fluosol-DA 20%, after massive postpartum hemorrhage.
Karn KE; Ogburn PL; Julian T; Cerra FB; Hammerschmidt DE; Vercellotti G
Obstet Gynecol; 1985 Jan; 65(1):127-30. PubMed ID: 3871250
[TBL] [Abstract][Full Text] [Related]
20. Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients.
Spence RK; McCoy S; Costabile J; Norcross ED; Pello M; Alexander J; Atabek U; Wisdom C; Camishion R
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1069. PubMed ID: 1391428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
